Ben Davidson

ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease

Nicoletta Colombo, Cristiana Sessa, Andreas du Bois et al. · Annals of Oncology · 2019 · 1.2K citations · Full text

Medicine, Oncology, Pathology +17

Redefining the relevance of established cancer cell lines to the study of mechanisms of clinical anti-cancer drug resistance

Jean-Pierre Gillet, Anna Maria Calcagno, Sudhir Varma et al. · Proceedings of the National Academy of Sciences · 2011 · 474 citations · Full text

Medicine, Cancer Biology, Oncology +16

Snail, Slug, and Smad‐interacting protein 1 as novel parameters of disease aggressiveness in metastatic ovarian and breast carcinoma

Sivan Elloul, Mari Bukholt Elstrand, Jahn M. Nesland et al. · Cancer · 2005 · 427 citations · Full text

Medicine, Oncology, Pathology +14

MicroRNA Expression and Identification of Putative miRNA Targets in Ovarian Cancer

Neetu Dahiya, Cheryl A. Sherman‐Baust, Tian‐Li Wang et al. · PLoS ONE · 2008 · 351 citations · Full text

Medicine, Molecular Biology, Oncology +17

Functional genomics identifies five distinct molecular subtypes with clinical relevance and pathways for growth control in epithelial ovarian cancer

Tuan Zea Tan, Qing Hao Miow, Ruby Yun‐Ju Huang et al. · EMBO Molecular Medicine · 2013 · 291 citations · Full text

Medicine, Molecular Biology, Oncology +17